Respiratory Multiplex RTPCR Kit
Detect SARS-CoV-2, Influenza A & B, and RSV AB simultaneously with high sensitivity and specificity. Compatible with multiple RTPCR instruments, delivering reliable results in just 1.5 hours.
Overview
The Respiratory Multiplex RTPCR Kit enables simultaneous detection of SARS-CoV-2, Influenza A, Influenza B, and RSV AB, along with an internal control gene. It works with extracted RNA samples from both upper and lower respiratory tracts and delivers reliable results across multiple RTPCR instruments.
Features
- Highly Specific : No cross-reactivity with human coronavirus strains or other respiratory pathogens.
- Ultra Sensitive : Detects multiple SARS-CoV-2 variants (Alpha, Beta, Gamma, Delta, Delta Plus, Kappa, Iota, Epsilon, Omicron) and low viral loads.
- Timesaving : Rapid processing in approximately 1.5 hours.
- Certified Quality : CE IVD marked with high-quality manufacturing from Northern Europe.
- Broad Compatibility : Works with most realtime PCR instruments with at least five measurement channels (FAM, HEX, Texas Red, CY5.5, CY5). Validated on BioRad CFX96, BioRad CFX Opus, and Applied Biosystems QuantStudio 5. Compatible with several commercial RNA extraction kits.
- Long Shelf Life : 12 months.
Technical Specifications
- Detection targets : SARS-CoV-2, Influenza A, Influenza B, RSV AB
- Sensitivity : Detects as low as 0.65 copies/µL of viral RNA
- Sample type : Extracted RNA from upper or lower respiratory tract
- Compatible instruments : BioRad CFX96, BioRad CFX Opus, Applied Biosystems QuantStudio 5, and others with ≥5 channels
- Shelf life : 12 months
Benefits
- Rapid, accurate detection of multiple respiratory pathogens in one test
- Reduces workflow complexity and turnaround time
- Supports early clinical decision-making and infection control